-
Je něco špatně v tomto záznamu ?
Investigation of sanguinarine and chelerythrine effects on CYP1A1 expression and activity in human hepatoma cells
Zdarilová A, Vrzal R, Rypka M, Ulrichová J, Dvorák Z.
Jazyk angličtina Země Velká Británie
NLK
ScienceDirect (archiv)
od 1993-01-01 do 2009-12-31
- MeSH
- alkaloidy farmakologie MeSH
- benzofenantridiny MeSH
- cytochrom P-450 CYP1A1 antagonisté a inhibitory biosyntéza MeSH
- cytochrom P-450 CYP1A2 biosyntéza MeSH
- fenantridiny farmakologie MeSH
- financování organizované MeSH
- hepatocelulární karcinom enzymologie MeSH
- inhibitory cytochromu P450 CYP1A2 MeSH
- inhibitory enzymů farmakologie MeSH
- isochinoliny MeSH
- katalýza MeSH
- lidé MeSH
- messenger RNA biosyntéza MeSH
- nádorové buněčné linie MeSH
- nádory jater enzymologie MeSH
- rekombinantní proteiny chemie MeSH
- Check Tag
- lidé MeSH
Quaternary benzo[c]phenanthridine alkaloids (QBA) sanguinarine and chelerythrine exhibit a wide spectrum of biological activities whence they are used in dental care products. Recent studies indicated that cytochrome P450 CYP1A attenuates sanguinarine toxicity both in vivo [Williams, M.K., Dalvi, S., Dalvi, R.R., 2000. Influence of 3-methylcholanthrene pretreatment on sanguinarine toxicity in mice. Vet. Hum. Toxicol. 42, 196-198] and in vitro [Vrba, J., Kosina, P., Ulrichová, J., Modrianský, M., 2004. Involvement of cytochrome P450 1A in sanguinarine detoxication. Toxicol. Lett. 151, 375-387]. However, CYP1A converts sanguinarine to the products that form DNA adducts [Stiborová, M., Simánek, V., Frei, E., Hobza, P., Ulrichová, J., 2002. DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique. Chem. Biol. Interact. 140, 231-242]. In our work we examined the effects of sanguinarine and chelerythrine on CYP1A1 expression and catalytic activity in human hepatoma cells-HepG2. Sanguinarine and chelerythrine did not affect basal and dioxin-inducible expression of CYP1A1 mRNA and protein in HepG2 cells. The enzymatic activity of CYP1A1 was assessed by the fluorescent measurement of 7-ethyxoresorufin-O-deethylase (EROD) activity. We observed a slight decrease of dioxin-induced EROD activity in HepG2 cells by sanguinarine and chelerythrine. This decrease was attributed to the inhibition of CYP1A1 catalytic activity, as revealed by enzyme kinetic studies on recombinant CYP1A1 protein. The IC50 values for the inhibition of CYP1A1 by sanguinarine and chelerythrine were 2.1 and 1.9muM, respectively. In conclusion, albeit the CYP1A modulates QBA cytotoxicity and genotoxicity, the QBA themselves do not affect CYP1A1 expression. The data indicate that studied alkaloids do not have specific cellular target and their biological effects are rather pleiotropic.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07520356
- 003
- CZ-PrNML
- 005
- 20111210131106.0
- 008
- 090331s2006 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Galandáková, Adéla, $d 1979- $7 stk2008428623
- 245 10
- $a Investigation of sanguinarine and chelerythrine effects on CYP1A1 expression and activity in human hepatoma cells / $c Zdarilová A, Vrzal R, Rypka M, Ulrichová J, Dvorák Z.
- 314 __
- $a Institute of Medical Chemistry and Biochemistry, Faculty of Medicine, Palacký University, Hnevotínská 3, 775 15 Olomouc, Czech Republic
- 520 9_
- $a Quaternary benzo[c]phenanthridine alkaloids (QBA) sanguinarine and chelerythrine exhibit a wide spectrum of biological activities whence they are used in dental care products. Recent studies indicated that cytochrome P450 CYP1A attenuates sanguinarine toxicity both in vivo [Williams, M.K., Dalvi, S., Dalvi, R.R., 2000. Influence of 3-methylcholanthrene pretreatment on sanguinarine toxicity in mice. Vet. Hum. Toxicol. 42, 196-198] and in vitro [Vrba, J., Kosina, P., Ulrichová, J., Modrianský, M., 2004. Involvement of cytochrome P450 1A in sanguinarine detoxication. Toxicol. Lett. 151, 375-387]. However, CYP1A converts sanguinarine to the products that form DNA adducts [Stiborová, M., Simánek, V., Frei, E., Hobza, P., Ulrichová, J., 2002. DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique. Chem. Biol. Interact. 140, 231-242]. In our work we examined the effects of sanguinarine and chelerythrine on CYP1A1 expression and catalytic activity in human hepatoma cells-HepG2. Sanguinarine and chelerythrine did not affect basal and dioxin-inducible expression of CYP1A1 mRNA and protein in HepG2 cells. The enzymatic activity of CYP1A1 was assessed by the fluorescent measurement of 7-ethyxoresorufin-O-deethylase (EROD) activity. We observed a slight decrease of dioxin-induced EROD activity in HepG2 cells by sanguinarine and chelerythrine. This decrease was attributed to the inhibition of CYP1A1 catalytic activity, as revealed by enzyme kinetic studies on recombinant CYP1A1 protein. The IC50 values for the inhibition of CYP1A1 by sanguinarine and chelerythrine were 2.1 and 1.9muM, respectively. In conclusion, albeit the CYP1A modulates QBA cytotoxicity and genotoxicity, the QBA themselves do not affect CYP1A1 expression. The data indicate that studied alkaloids do not have specific cellular target and their biological effects are rather pleiotropic.
- 650 _2
- $a alkaloidy $x farmakologie $7 D000470
- 650 _2
- $a benzofenantridiny $7 D053119
- 650 _2
- $a hepatocelulární karcinom $x enzymologie $7 D006528
- 650 _2
- $a katalýza $7 D002384
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a cytochrom P-450 CYP1A1 $x antagonisté a inhibitory $x biosyntéza $7 D019363
- 650 _2
- $a cytochrom P-450 CYP1A2 $x biosyntéza $7 D019388
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a isochinoliny $7 D007546
- 650 _2
- $a nádory jater $x enzymologie $7 D008113
- 650 _2
- $a fenantridiny $x farmakologie $7 D010617
- 650 _2
- $a messenger RNA $x biosyntéza $7 D012333
- 650 _2
- $a rekombinantní proteiny $x chemie $7 D011994
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a inhibitory cytochromu P450 CYP1A2 $7 D065609
- 700 1_
- $a Vrzal, Radim $7 xx0118949
- 700 1_
- $a Rypka, Miroslav. $7 ola2015882127
- 700 1_
- $a Ulrichová, Jitka, $d 1956- $7 ola2002158251
- 700 1_
- $a Dvořák, Zdeněk, $d 1974- $7 xx0118950
- 773 0_
- $w MED00001825 $t Food and chemical toxicology $g Roč. 44, č. 2 (2006), s. 242-249 $x 0278-6915
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090325104238 $b ABA008
- 991 __
- $a 20090713154942 $b ABA008
- 999 __
- $a ok $b bmc $g 638159 $s 490958
- BAS __
- $a 3
- BMC __
- $a 2006 $b 44 $c 2 $d 242-249 $i 0278-6915 $m Food and chemical toxicology $x MED00001825
- LZP __
- $a 2009-B1/dkme